Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Buy
1,528
+201
+15% +$43.2K 0.08% 197
2026
Q1
$289K Buy
1,327
+59
+5% +$13.1K 0.07% 194
2025
Q4
$290K Buy
1,268
+11
+0.9% +$2.51K 0.07% 195
2025
Q3
$291K Sell
1,257
-2
-0.2% -$407 0.07% 199
2025
Q2
$234K Buy
1,259
+24
+2% +$4.46K 0.06% 212
2025
Q1
$259K Buy
1,235
+45
+4% +$8.75K 0.08% 192
2024
Q4
$212K Buy
1,190
+64
+6% +$11.8K 0.06% 219
2024
Q3
$222K Buy
+1,126
New +$210K 0.06% 218
2023
Q1
$219K Sell
1,359
-113
-8% -$17.3K 0.08% 198
2022
Q4
$238K Sell
1,472
-180
-11% -$27.6K 0.09% 195
2022
Q3
$237K Buy
1,652
+151
+10% +$21.7K 0.09% 192
2022
Q2
$231K Buy
1,501
+33
+2% +$5.04K 0.09% 199
2022
Q1
$239K Sell
1,468
-44
-3% -$6.39K 0.08% 205
2021
Q4
$204K Buy
+1,512
New +$179K 0.07% 219
2021
Q1
Sell
-2,183
Closed -$230K 214
2020
Q4
$230K Sell
2,183
-253
-10% -$24.3K 0.1% 170
2020
Q3
$213K Sell
2,436
-15
-0.6% -$1.41K 0.11% 166
2020
Q2
$241K Buy
+2,451
New +$216K 0.13% 151

Other funds holding ABBV

Old Port Advisors's ABBV Position: Q2 2026 in Review

Old Port Advisors increased its AbbVie (ABBV) stake by 15% in Q2 2026, buying an estimated $43.2K and bringing the position to 1,528 shares worth $385K. The position accounts for 0.08% of the portfolio, ranked #197.

Old Port Advisors first reported a position in ABBV in Q2 2020 and has held it in 17 quarters since. 1,347 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Old Port Advisors held 1,528 shares of AbbVie worth $385K as of Q2 2026.
  • Old Port Advisors bought 201 AbbVie shares in Q2 2026, an estimated $43.2K.
  • AbbVie made up 0.08% of Old Port Advisors's portfolio in Q2 2026, its #197 holding.
  • Old Port Advisors first reported a position in AbbVie in Q2 2020 and has held it in 17 quarters since.
  • 1,347 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.